FAM
IONS icon

Fred Alger Management’s Ionis Pharmaceuticals IONS Stock Holding History

Fred Alger Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.26M Buy
78,932
+50,480
+177% +$3.8M 0.02% 217
2026
Q1 		$2.14M Sell
28,452
-9,971
-26% -$787K 0.01% 311
2025
Q4 		$3.04M Sell
38,423
-3,978
-9% -$300K 0.01% 285
2025
Q3 		$2.77M Buy
42,401
+32,937
+348% +$1.61M 0.01% 300
2025
Q2 		$374K Buy
+9,464
New +$310K ﹤0.01% 394
2024
Q1 		– Sell
-24,054
Closed -$1.22M – 469
2023
Q4 		$1.22M Buy
24,054
+10,488
+77% +$502K 0.01% 362
2023
Q3 		$615K Buy
+13,566
New +$560K ﹤0.01% 370
2023
Q2 		– Sell
-499
Closed -$17.8K – 545
2023
Q1 		$17.8K Sell
499
-189,854
-100% -$7.13M ﹤0.01% 500
2022
Q4 		$7.19M Buy
190,353
+47,831
+34% +$2.01M 0.04% 232
2022
Q3 		$6.3M Sell
142,522
-4,134
-3% -$174K 0.03% 239
2022
Q2 		$5.43M Buy
+146,656
New +$5.53M 0.03% 258
2019
Q4 		– Sell
-190
Closed -$11K – 501
2019
Q3 		$11K Sell
190
-240
-56% -$15.6K ﹤0.01% 472
2019
Q2 		$28K Buy
430
+189
+78% +$13.4K ﹤0.01% 437
2019
Q1 		$20K Buy
+241
New +$15.5K ﹤0.01% 439
2018
Q2 		– Sell
-4,000
Closed -$176K – 562
2018
Q1 		$176K Buy
+4,000
New +$203K ﹤0.01% 398
2017
Q1 		– Sell
-6,000
Closed -$287K – 538
2016
Q4 		$287K Buy
+6,000
New +$237K ﹤0.01% 344
2015
Q2 		– Sell
-161,972
Closed -$10.3M – 517
2015
Q1 		$10.3M Sell
161,972
-125,107
-44% -$8.49M 0.05% 260
2014
Q4 		$17.7M Buy
287,079
+143,042
+99% +$7.06M 0.09% 195
2014
Q3 		$5.59M Sell
144,037
-30,413
-17% -$1.08M 0.03% 328
2014
Q2 		$6.01M Sell
174,450
-156,405
-47% -$4.92M 0.03% 344
2014
Q1 		$14.3M Buy
330,855
+48,395
+17% +$2.35M 0.07% 263
2013
Q4 		$11.3M Buy
+282,460
New +$10.1M 0.06% 289

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fred Alger Management's IONS Position: Q2 2026 in Review

Fred Alger Management increased its Ionis Pharmaceuticals (IONS) stake by 177% in Q2 2026, buying an estimated $3.8M and bringing the position to 78,932 shares worth $6.26M. The position accounts for 0.02% of the portfolio, ranked #217.

Fred Alger Management first reported a position in IONS in Q4 2013 and has held it in 22 quarters since. The position peaked at $17.7M in Q4 2014. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Fred Alger Management held 78,932 shares of Ionis Pharmaceuticals worth $6.26M as of Q2 2026.
  • Fred Alger Management bought 50,480 Ionis Pharmaceuticals shares in Q2 2026, an estimated $3.8M.
  • Ionis Pharmaceuticals made up 0.02% of Fred Alger Management's portfolio in Q2 2026, its #217 holding.
  • Fred Alger Management first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 22 quarters since.
  • Fred Alger Management's Ionis Pharmaceuticals position peaked at $17.7M in Q4 2014.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.